TOP STORIES

• REGULATORY Japan Drug Spending Up 2.3% Annually Since 2000, Outstripping GDP Growth: MOF
  November 9, 2021

• REGULATORY MHLW Panel Tables Decision on Efient’s Preventive Use for ICD Recurrences; Lilly's Migraine Med, Jardiance's Heart Failure Indication OK'ed
  November 9, 2021

• REGULATORY Chuikyo Calls for Combining Multiple Steps to Curb Spend for Potential Super Big Sellers Like Aducanumab, No Objection to Listing
  November 8, 2021

• REGULATORY Japan Approves Ronapreve to Prevent Symptomatic COVID-19
  November 5, 2021

• BUSINESS New EA Pharma CEO Eager to Put Company Back on Growth Track by Boosting Its Sales Strength
  November 5, 2021

• REGULATORY Ronapreve Clears Key Panel for COVID-19 Prevention, SC Use
  November 5, 2021

• BUSINESS 7 Major Japan Drug Makers Net Two-Digit Growth in Combined H1 Sales on Flagship Brands, Upfront Income
  November 4, 2021

• BUSINESS Shionogi Wants to Pick Global Partner for Oral COVID-19 Drug by Year-End: President
  November 2, 2021

• BUSINESS Daiichi Sankyo Launches Oncolytic Virus Delytact in Japan
  November 2, 2021

• BUSINESS Hypertension OK Now in Hand, Novartis Expanding Entresto Pitch to GPs with Superior Efficacy over ARBs
  November 1, 2021

• BUSINESS Senju Gearing Up to Grow Lucentis Biosimilar into Its Mainstay Product
  November 1, 2021

• ORGANIZATION PhRMA Reserves Opinion on INES Proposal, but Says No to Any Cherry-Picking
  October 29, 2021

• REGULATORY Late-Phase Trials with Overseas Participation Pragmatic Approach for Japan-Made COVID-19 Vaccine Development: PMDA Director
  October 29, 2021

• REGULATORY Ronapreve Up for PAFSC Review for Preventive Use on Nov. 4
  October 29, 2021

• BUSINESS Sumitomo Dainippon to Speed Up Development of CNS Blockbuster Hopeful through Otsuka Alliance
  October 28, 2021

• BUSINESS CNS Alliance with Otsuka Expected to be Long-term: Sumitomo Dainippon Senior Executive
  October 28, 2021

• BUSINESS Sun Pharma Japan to Boost Sales Force, Development to Achieve 1.5-Fold Sales Growth by 2025
  October 27, 2021

• COMMENTARY SGLT2 Inhibitors, Entresto Could Change Paradigm of Treatment of Heart Failure: JHFS Annual Confab
  October 26, 2021

• BUSINESS KM Biologics Eyes COVID-19 Booster Filing as Early as Spring, Trial Start Slated by Year-End
  October 26, 2021

• ORGANIZATION Main Focus of INES Proposal Is Securing Resources to Reward Innovation, Not Macroeconomic Indexing
  October 25, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• …
• Next ›
• 最終 »